Equities research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright boosted their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Stock Analysis on SenesTech
SenesTech Stock Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- Transportation Stocks Investing
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- The Significance of Brokerage Rankings in Stock Selection
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.